Correspondingly, treatment with BM-NK from Smad3 knockout mice resulted in a 2.5-fold increase in the inhibition of LLC progression, which was voided by disrupting GM-CSF production as indicated by both tumor volume and tumor weight in Fig. 2C and D. Here, SMAD3 is linked to neoplasm.